These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19842228)

  • 21. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer].
    Jia WD; Wang W; Tang ZY; Xu GL; Sun HC; Zhou HJ
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):241-5. PubMed ID: 19615273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma.
    Xu L; Tong X; Zhang S; Yin F; Li X; Wei H; Li C; Guo Y; Zhao J
    Tumour Biol; 2016 Oct; 37(10):13669-13677. PubMed ID: 27473084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Ma Y; Wang J; Liu L; Zhu H; Chen X; Pan S; Sun X; Jiang H
    Cancer Lett; 2011 Feb; 301(1):75-84. PubMed ID: 21078540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of canstatin and arsenic trioxide suppresses the development of hepatocellular carcinoma.
    Zhang F; Duan J; Song H; Yang L; Zhou M; Wang X
    Drug Dev Res; 2021 May; 82(3):430-439. PubMed ID: 33244794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo.
    Peng R; Zhao GX; Li J; Zhang Y; Shen XZ; Wang JY; Sun JY
    World J Gastroenterol; 2016 Mar; 22(12):3341-54. PubMed ID: 27022216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of proliferation and induction of G1-phase cell-cycle arrest by dFMGEN, a novel genistein derivative, in lung carcinoma A549 cells.
    Peng B; Cao J; Yi S; Wang C; Zheng G; He Z
    Drug Chem Toxicol; 2013 Apr; 36(2):196-204. PubMed ID: 22931124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of the Chinese herbal extract Songyou Yin on the residual hepatocellular carcinoma after chemotherapy in nude mice].
    Xiong W; Tang ZY; Ren ZG; Huang XY; Jia QA; Xie XY; Shen HJ
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):804-7. PubMed ID: 24447475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitory effects of recombinant human endostatin on the metastatic potential and invasiveness of hepatocellular carcinoma HCCLM6 cells in vitro].
    Zhang PH; Qin J; Li AM; Ding XM; Yang-feng D; Rong-cheng L
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):658-61. PubMed ID: 18495614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway.
    Li D; Zhang B; Hu C
    Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):581-587. PubMed ID: 28475688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
    Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1.
    Dai W; Wang F; He L; Lin C; Wu S; Chen P; Zhang Y; Shen M; Wu D; Wang C; Lu J; Zhou Y; Xu X; Xu L; Guo C
    Mol Carcinog; 2015 Apr; 54(4):301-11. PubMed ID: 24243709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contributions of lung tissue extracts to invasion and migration of human hepatocellular carcinoma cells with various metastatic potentials.
    Ji XN; Ye SL; Li Y; Tian B; Chen J; Gao DM; Chen J; Bao WH; Liu YK; Tang ZY
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):556-64. PubMed ID: 12942314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of saracatinib on pulmonary metastases from hepatocellular carcinoma.
    Xiong J; Wu JS; Mao SS; Yu XN; Huang XX
    Oncol Rep; 2016 Sep; 36(3):1483-90. PubMed ID: 27460949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line.
    Li GC; Ye QH; Xue YH; Sun HJ; Zhou HJ; Ren N; Jia HL; Shi J; Wu JC; Dai C; Dong QZ; Qin LX
    Cancer Sci; 2010 Dec; 101(12):2546-53. PubMed ID: 20942864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death.
    Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C
    Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice.
    Cao B; Chen XP; Zhu P; Ding L; Guan J; Shi ZL
    World J Gastroenterol; 2008 Nov; 14(44):6802-7. PubMed ID: 19058305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.